Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: procedure (650), etiquette (1), practice (609)

Form_020_Sponsor_Request_Form_v3_03-01-2020

Description: UHS Sponsorship Application Section 1 – To be completed for all projects requesting UHS to act as Sponsor Study
Url: /Media/Southampton-Clinical-Research/Downloads/Form-020-Sponsor-Request-Form-v3-03-01-2020.docx

Press release: Pioneering therapy dog study shows overwhelming support from staff and patients for nationwide rollout

Description: A pioneering study into the effect of therapy dogs on the wards at Southampton Children's Hospital has shown overwhelming support from
Url: /AboutTheTrust/Newsandpublications/Latestnews/2019/May/Press-release-Pioneering-therapy-dog-study-shows-overwhelming-support-from-staff-and-patients-for-nationwide-rollout.aspx

SOP setting up a new trial in shared care centre - 1 February 2013

Description: Paediatric Oncology UHSStandard Operating ProcedureOpening a New Trial in an Shared Care Centre (POSCU)SOP Number: Version Number and Date:PB_TR
Url: /Media/UHS-website-2019/Docs/PaediatricOncology/POSCU/SOP-Setting-up-a-new-trial-in-shared-care-centre-01-02-2013.pdf

Handling concerns and complaints policy

Description: Handling Complaints Policy, Version 13.0 Trust reference PET003 Version number 13.0 Description Policy to explain how University H
Url: /Media/UHS-website-2019/Docs/Policies/Handling-concerns-and-complaints-policy.pdf

AmB - Cytarabine(1500)

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AmB- CYTARABINE (1500mg/m2) Ambulatory Regimen This regimen is for AMBULATORY CARE pathway use only Regimen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmB-Cytarabine1500-Ver-1.pdf

Loncastuximab

Description: Chemotherapy Protocol LYMPHOMA LONCASTUXIMAB TESIRINE Regimen • Diffuse Large B-Cell Lymphoma (DLBCL) / High Grade B-Cell Lymphoma (HGBL) Loncastuximab Tesirine Monotherapy
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Loncastuximab.pdf

AmB - Cytarabine(3000)

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AmB- CYTARABINE (3000mg/m2) Ambulatory Regimen This regimen is for AMBULATORY CARE pathway use only Regimen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmB-Cytarabine-3000.pdf

Papers Trust Board - 9 September 2025

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 09/09/2025 9:00 - 13:00 Conference Room, Heartbeat Education
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-9-September-2025.pdf

InP IVE-Epirubicin-Etoposide-Ifosfamide Ver1.1

Description: Chemotherapy Protocol LYMPHOMA EPIRUBICIN-ETOPOSIDE-IFOSFAMIDE (IVE) Inpatient Regimen Regimen • Lymphoma – InP-IVE-Epirubicin-Etoposide-Ifosfamide Indication • Non Hodgkin’s Lymphoma
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-IVE-Epirubicin-Etoposide-Ifosfamide.pdf

HSCT Amb Melphalan-Bortezomib SC

Description: Chemotherapy Protocol HAEMATOLOGY – HSCT AUTOGRAFT AMBULATORY MELPHALAN and BORTEZOMIB SC Multiple Myeloma This regimen will only be available to prescribe at
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCT-Amb-Melphalan-Bortezomib-SC-Ver1.pdf

441 to 450 of 698

Previous … 43 44 45 46 47 … Next